Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-FIXa and anti-FX IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-FIXa x Human Anti-FX Bispecific Antibody (scIgG) (SCIGG-H328). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS